Finally, the DMXAA-induced regression of spontaneous tumors after anti-TGFβ treatment is transient, indicating that the initial innate responses would deserve being reinforced and prolonged by a treatment boosting the endogenous adaptive anti-tumor response. Here, TGFB1 is linked to neoplasm.